These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 37106558)

  • 21. Breast MRI background parenchymal enhancement as an imaging bridge to molecular cancer sub-type.
    Dilorenzo G; Telegrafo M; La Forgia D; Stabile Ianora AA; Moschetta M
    Eur J Radiol; 2019 Apr; 113():148-152. PubMed ID: 30927939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical Surrogates for Molecular Classification of Breast Carcinoma: A 2015 Update.
    Tang P; Tse GM
    Arch Pathol Lab Med; 2016 Aug; 140(8):806-14. PubMed ID: 27472239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic Significance of Progesterone Receptor Expression in Estrogen-Receptor Positive, HER2-Negative, Node-Negative Invasive Breast Cancer With a Low Ki-67 Labeling Index.
    Ono M; Tsuda H; Yoshida M; Shimizu C; Kinoshita T; Tamura K
    Clin Breast Cancer; 2017 Feb; 17(1):41-47. PubMed ID: 27477822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of neoadjuvant chemotherapy on hormone receptor status, HER2/neu and prolactin in breast cancer.
    Pedrini JL; Francalacci Savaris R; Casales Schorr M; Cambruzi E; Grudzinski M; Zettler CG
    Tumori; 2011; 97(6):704-10. PubMed ID: 22322835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analytical and clinical performance of progesterone receptor antibodies in breast cancer.
    Calhoun BC; Mosteller B; Warren D; Smith M; Jordi Rowe J; Lanigan CP; Mrazeck KC; Walker E; Newell AH; Jones R
    Ann Diagn Pathol; 2018 Aug; 35():21-26. PubMed ID: 29758480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Over-expression of c-erbB-2 correlates with nuclear morphometry and prognosis in breast carcinoma in Asian women.
    Selvarajan S; Wong KY; Khoo KS; Bay BH; Tan PH
    Pathology; 2006 Dec; 38(6):528-33. PubMed ID: 17393979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ERα-36 regulates progesterone receptor activity in breast cancer.
    Konan HP; Kassem L; Omarjee S; Surmieliova-Garnès A; Jacquemetton J; Cascales E; Rezza A; Trédan O; Treilleux I; Poulard C; Le Romancer M
    Breast Cancer Res; 2020 May; 22(1):50. PubMed ID: 32429997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association Between Metabolic Syndrome and Immunohistochemical Profile at Breast Cancer Diagnosis in Postmenopausal Women.
    Motoki AH; Buttros DAB; Gaspar AL; Almeida-Filho BS; Carvalho-Pessoa E; Vespoli HDL; Nahas-Neto J; Nahas EAP
    Clin Breast Cancer; 2022 Feb; 22(2):e253-e261. PubMed ID: 34465534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a Low-Risk Luminal A Breast Cancer Cohort That May Not Benefit From Breast Radiotherapy.
    Liu FF; Shi W; Done SJ; Miller N; Pintilie M; Voduc D; Nielsen TO; Nofech-Mozes S; Chang MC; Whelan TJ; Weir LM; Olivotto IA; McCready DR; Fyles AW
    J Clin Oncol; 2015 Jun; 33(18):2035-40. PubMed ID: 25964246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer.
    Nishimukai A; Yagi T; Yanai A; Miyagawa Y; Enomoto Y; Murase K; Imamura M; Takatsuka Y; Sakita I; Hatada T; Miyoshi Y
    Clin Breast Cancer; 2015 Jun; 15(3):204-11. PubMed ID: 25600243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular Subtypes and Prognosis in Young Mexican Women With Breast Cancer.
    Villarreal-Garza C; Mohar A; Bargallo-Rocha JE; Lasa-Gonsebatt F; Reynoso-Noverón N; Matus-Santos J; Cabrera P; Arce-Salinas C; Lara-Medina F; Alvarado-Miranda A; Ramírez-Ugalde MT; Soto-Perez-de-Celis E
    Clin Breast Cancer; 2017 Jun; 17(3):e95-e102. PubMed ID: 28065398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concordance of the molecular subtype classification between core needle biopsy and surgical specimen in primary breast cancer.
    Pölcher M; Braun M; Tischitz M; Hamann M; Szeterlak N; Kriegmair A; Brambs C; Becker C; Stoetzer O
    Arch Gynecol Obstet; 2021 Sep; 304(3):783-790. PubMed ID: 33585986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic Significance of Single Progesterone Receptor Positivity: A Comparison Study of Estrogen Receptor Negative/Progesterone Receptor Positive/Her2 Negative Primary Breast Cancer With Triple Negative Breast Cancer.
    Fan Y; Ding X; Xu B; Ma F; Yuan P; Wang J; Zhang P; Li Q; Luo Y
    Medicine (Baltimore); 2015 Nov; 94(46):e2066. PubMed ID: 26579819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinico-morphological significance of spontaneous necrosis in breast cancer].
    Kriuchkov AN
    Vopr Onkol; 2007; 53(2):229-34. PubMed ID: 17663181
    [No Abstract]   [Full Text] [Related]  

  • 35. Targeted Combinations for Hormone Receptor-Positive Advanced Breast Cancer: Who Benefits?
    Johnston SR
    J Clin Oncol; 2016 Feb; 34(5):393-5. PubMed ID: 26700117
    [No Abstract]   [Full Text] [Related]  

  • 36. IMP3 expression in triple-negative breast carcinoma.
    Sidoni A; Cartaginese F
    Hum Pathol; 2010 Sep; 41(9):1355-6; author reply 1356-7. PubMed ID: 20708461
    [No Abstract]   [Full Text] [Related]  

  • 37. [Updated CAP guidelines for determining molecular biological subtypes of breast cancer].
    Zavalishina LE; Oliushina EM; Andreeva YY; Kuznetsova OA; Moskvina LV; Frank GA
    Arkh Patol; 2023; 85(4):39-46. PubMed ID: 37530189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Androgen receptor expression in a Sri Lankan patient cohort with early breast carcinoma.
    Wijesinghe HD; Wijesinghe GK; Mansoor Z; Vigneshwara S; Fernando J; Gunasekera D; Lokuhetty MDS
    BMC Womens Health; 2020 Sep; 20(1):206. PubMed ID: 32928183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Locoregional recurrence by molecular subtype after multicatheter interstitial accelerated partial breast irradiation: Results from the Pooled Registry Of Multicatheter Interstitial Sites research group.
    Anderson BM; Kamrava M; Wang PC; Chen P; Demanes DJ; Hayes JK; Kuske RR
    Brachytherapy; 2016; 15(6):788-795. PubMed ID: 27743957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer.
    Park C; Park K; Kim J; Sin Y; Park I; Cho H; Yang K; Bae BN; Kim KW; Ahn S; Gwak G
    World J Surg Oncol; 2016 Sep; 14(1):244. PubMed ID: 27619909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.